We are one of Europe’s largest manufacturers of extemporaneous medicines and a leading contract manufacturer within the life science sector.
Our task is to develop and manufacture individually adapted medicines for patients with additional needs, such as children who need specific concentrations or flavors, and patients with various difficulties. Our operations are carried out in close collaboration with specialists, county councils and public agencies to ensure patients have access to the right treatments.
APL also offers contract development and manufacturing services to biotechnology and pharmaceutical companies. We have resources to develop, manufacture and analyze specialist medicines and other niche products.
The Swedish pharmacy sector was nationalized in the early 1970s, and Apoteksbolaget AB was formed. The company included Apotek Produktion & Laboratorium AB (APL), tasked with providing prescribers with extemporaneous medicines or specially manufactured formulations for individually adapted treatments for their patients. With the deregulation of the pharmacy market in 2009, pharmacies were no longer allowed to produce medicines, and therefore APL was disconnected from Apoteket AB in June 2010.
We make a difference for patients with additional needs
We develop and manufacture extemporaneous and orphan drugs as part of a public policy assignment and on behalf of other pharmaceutical companies, to bring the greatest possible benefit to patients.
View an intensive and carefully controlled process in sterile manufacturing at APL.
We constantly analyze our activities, products and services to identify improvements relating to quality, the natural environment and society.
We welcome skilled and solution-oriented employees, offering exceptional development opportunities in an exciting industry.
780 mkr
Net turnover
2 000
Extemporaneous medicines
484
Number of employees